Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Holley price target lowered to $5 from $9 at DA Davidson » 08:27
11/15/22
11/15
08:27
11/15/22
08:27
HLLY

Holley

$2.98 /

-0.215 (-6.74%)

DA Davidson analyst…

DA Davidson analyst Michael Baker lowered the firm's price target on Holley to $5 from $9 but keeps a Buy rating on the shares after its Q3 results. The analyst states that he had previously written that the worst of the supply chain was behind Holley, and this still appears to be the case as the company's ability to ship product to retailers improved throughout the quarter. Baker adds however that even though the situation looks much better than three months ago, the issues are not fully solved, leading to a Q4 guide-down. The analyst still contends however that Holley did a "good job showing that it is not a demand issue, but a supply issue, which is improving".

ShowHide Related Items >><<
HLLY Holley
$2.98 /

-0.215 (-6.74%)

HLLY Holley
$2.98 /

-0.215 (-6.74%)

11/15/22 Raymond James
Holley price target lowered to $5 from $9 at Raymond James
10/05/22 Truist
Holley price target lowered to $8 from $10 at Truist
08/12/22 Truist
Holley price target lowered to $10 from $15 at Truist
08/09/22 Imperial Capital
Holley initiated with an Outperform at Imperial Capital
HLLY Holley
$2.98 /

-0.215 (-6.74%)

  • 21
    Apr
HLLY Holley
$2.98 /

-0.215 (-6.74%)

Recommendations
Holley price target lowered to $5 from $9 at Raymond James » 07:12
11/15/22
11/15
07:12
11/15/22
07:12
HLLY

Holley

$2.98 /

-0.215 (-6.74%)

Raymond James analyst…

Raymond James analyst Joseph Altobello lowered the firm's price target on Holley to $5 from $9 and keeps an Outperform rating on the shares. Holley reported very choppy Q3 results that generally fell short of expectations, again weighed down by several ongoing headwinds, most notably microchip supply chain issues and channel destocking, Altobello tells investors in a research note.

ShowHide Related Items >><<
HLLY Holley
$2.98 /

-0.215 (-6.74%)

HLLY Holley
$2.98 /

-0.215 (-6.74%)

10/05/22 Truist
Holley price target lowered to $8 from $10 at Truist
08/12/22 Truist
Holley price target lowered to $10 from $15 at Truist
08/09/22 Imperial Capital
Holley initiated with an Outperform at Imperial Capital
07/29/22 Jefferies
Holley downgraded to Hold on business deceleration at Jefferies
HLLY Holley
$2.98 /

-0.215 (-6.74%)

  • 21
    Apr
HLLY Holley
$2.98 /

-0.215 (-6.74%)

On The Fly
Fly Intel: After-Hours Movers » 19:00
11/14/22
11/14
19:00
11/14/22
19:00
SHLS

Shoals Technologies

$22.49 /

-0.265 (-1.16%)

, HLLY

Holley

$2.98 /

-0.215 (-6.74%)

, TDUP

ThredUP

/

+

, ACLX

Arcellx

$21.54 /

-0.88 (-3.93%)

, NRDY

Nerdy

$2.14 /

-0.195 (-8.35%)

, FXLV

F45 Training

$3.21 /

-0.26 (-7.49%)

, DLO

dLocal

$22.62 /

-0.18 (-0.79%)

, TSM

TSMC

$72.81 /

-1.02 (-1.38%)

, POWW

AMMO

$3.16 /

+0.05 (+1.61%)

, TXMD

TherapeuticsMD

$6.51 /

-0.44 (-6.33%)

, GAN

Gan Limited

$1.70 /

+0.02 (+1.19%)

, QRHC

Quest Resource

$8.36 /

-0.47 (-5.32%)

, DNA

Ginkgo Bioworks

$2.69 /

-0.17 (-5.95%)

, NRGV

Energy Vault

$3.21 /

+0.015 (+0.47%)

, AXDX

Accelerate Diagnostics

$1.50 /

+0.08 (+5.63%)

, BLU

Bellus Health

$9.07 /

-0.22 (-2.37%)

, AZTA

Azenta

$46.60 /

-2.41 (-4.92%)

Check out this evening's…

ShowHide Related Items >><<
TXMD TherapeuticsMD
$6.51 /

-0.44 (-6.33%)

TSM TSMC
$72.81 /

-1.02 (-1.38%)

TDUP ThredUP
/

+

SHLS Shoals Technologies
$22.49 /

-0.265 (-1.16%)

QRHC Quest Resource
$8.36 /

-0.47 (-5.32%)

POWW AMMO
$3.16 /

+0.05 (+1.61%)

NRGV Energy Vault
$3.21 /

+0.015 (+0.47%)

NRDY Nerdy
$2.14 /

-0.195 (-8.35%)

HLLY Holley
$2.98 /

-0.215 (-6.74%)

GAN Gan Limited
$1.70 /

+0.02 (+1.19%)

FXLV F45 Training
$3.21 /

-0.26 (-7.49%)

DNA Ginkgo Bioworks
$2.69 /

-0.17 (-5.95%)

BLU Bellus Health
$9.07 /

-0.22 (-2.37%)

AZTA Azenta
$46.60 /

-2.41 (-4.92%)

AXDX Accelerate Diagnostics
$1.50 /

+0.08 (+5.63%)

ACLX Arcellx
$21.54 /

-0.88 (-3.93%)

SHLS Shoals Technologies
$22.49 /

-0.265 (-1.16%)

11/10/22 Morgan Stanley
New California 'NEM 3.0' proposal 'screens positive,' says Morgan Stanley
10/20/22 JPMorgan
Shoals Technologies price target lowered to $32 from $35 at JPMorgan
09/16/22 Cowen
Cowen upgrades Shoals to Outperform, sees 'compelling opportunity'
09/16/22 Cowen
Shoals Technologies upgraded to Outperform from Market Perform at Cowen
HLLY Holley
$2.98 /

-0.215 (-6.74%)

10/05/22 Truist
Holley price target lowered to $8 from $10 at Truist
08/12/22 Truist
Holley price target lowered to $10 from $15 at Truist
08/09/22 Imperial Capital
Holley initiated with an Outperform at Imperial Capital
07/29/22 Jefferies
Holley downgraded to Hold on business deceleration at Jefferies
TDUP ThredUP
/

+

08/15/22 Barclays
ThredUP assumed with an Overweight at Barclays
07/22/22 Piper Sandler
ThredUP downgraded to Neutral from Overweight at Piper Sandler
07/21/22 KeyBanc
KeyBanc transitions coverage of Global Brands & E-Commerce with cautious view
07/20/22 KeyBanc
ThredUP initiated with a Sector Weight at KeyBanc
ACLX Arcellx
$21.54 /

-0.88 (-3.93%)

10/31/22 Guggenheim
Arcellx initiated with a Buy at Guggenheim
10/27/22 Needham
Arcellx initiated with a Buy at Needham
07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
07/20/22 Canaccord
Arcellx initiated with a Buy at Canaccord
NRDY Nerdy
$2.14 /

-0.195 (-8.35%)

10/18/22 Barclays
Nerdy price target lowered to $2.50 from $4 at Barclays
06/29/22 JPMorgan
Nerdy price target lowered to $6 from $7 at JPMorgan
05/27/22 Canaccord
Nerdy price target lowered to $7 from $8 at Canaccord
05/17/22 JMP Securities
Nerdy price target lowered to $7 from $11 at JMP Securities
FXLV F45 Training
$3.21 /

-0.26 (-7.49%)

10/04/22 JPMorgan
F45 Training assumed with Neutral from Overweight at JPMorgan
08/16/22 Roth Capital
F45 Training reinstated with a Neutral at Roth Capital
07/28/22 Guggenheim
F45 Training downgraded to Neutral at Guggenheim on near-term uncertainty
07/28/22 Guggenheim
F45 Training downgraded to Neutral from Buy at Guggenheim
DLO dLocal
$22.62 /

-0.18 (-0.79%)

09/26/22 SMBC Nikko
dLocal downgraded to Underperform from Neutral at SMBC Nikko
05/19/22 Citi
dLocal price target lowered to $26 from $31 at Citi
05/09/22 New Street
New Street upgrades dLocal to Buy, sees good entry point
05/09/22 New Street
dLocal upgraded to Buy from Neutral at New Street
TSM TSMC
$72.81 /

-1.02 (-1.38%)

10/17/22 Northland
Teradyne price target lowered to $74 from $85 at Northland
10/13/22 Goldman Sachs
TSMC downgraded to Buy from Conviction Buy at Goldman Sachs
10/10/22 Northland
Intel price target lowered to $52 from $55 at Northland
09/14/22 Daiwa
TSMC upgraded to Buy from Outperform at Daiwa
POWW AMMO
$3.16 /

+0.05 (+1.61%)

08/16/22 Lake Street
AMMO price target lowered to $9 from $12 at Lake Street
06/30/22 EF Hutton
AMMO shares should be bought 'aggressively,' says EF Hutton
TXMD TherapeuticsMD
$6.51 /

-0.44 (-6.33%)

07/15/22 H.C. Wainwright
H.C. Wainwright suspends rating on TherapeuticsMD with merger terminated
06/07/22 H.C. Wainwright
TherapeuticsMD downgraded to Neutral from Buy at H.C. Wainwright
05/06/22 Cantor Fitzgerald
TherapeuticsMD downgraded to Neutral from Overweight at Cantor Fitzgerald
05/06/22 Cantor Fitzgerald
TherapeuticsMD downgraded to Neutral from Overweight at Cantor Fitzgerald
GAN Gan Limited
$1.70 /

+0.02 (+1.19%)

09/29/22 Northland
Gan Limited price target lowered to $2.50 from $3.50 at Northland
06/28/22 B. Riley
Gan Limited price target lowered to $6.50 from $10 at B. Riley
03/23/22 Craig-Hallum
Gan Limited price target lowered to $8 from $14 at Craig-Hallum
03/23/22 B. Riley
Gan Limited price target lowered to $10 from $26 at B. Riley
QRHC Quest Resource
$8.36 /

-0.47 (-5.32%)

04/18/22 EF Hutton
Quest Resource initiated with a Buy at EF Hutton
02/14/22 Craig-Hallum
Craig-Hallum bullish on Quest Resource, initiates with a Buy
02/14/22 Craig-Hallum
Quest Resource initiated with a Buy at Craig-Hallum
12/10/21 H.C. Wainwright
Quest Resource price target raised to $12 from $10 at H.C. Wainwright
DNA Ginkgo Bioworks
$2.69 /

-0.17 (-5.95%)

10/04/22 Morgan Stanley
Ginkgo Bioworks initiated with an Equal Weight at Morgan Stanley
08/16/22 BTIG
Ginkgo Bioworks price target raised to $6 from $5 at BTIG
08/16/22 Raymond James
Ginkgo Bioworks price target raised to $14.50 from $11.50 at Raymond James
07/26/22 William Blair
Zymergen buyout deal 'best case scenario,' says William Blair
NRGV Energy Vault
$3.21 /

+0.015 (+0.47%)

10/06/22 Guggenheim
Energy Vault price target lowered to $10 from $15 at Guggenheim
08/09/22 Cowen
Energy Vault price target lowered to $11.50 from $18 at Cowen
06/29/22 Chardan
Energy Vault initiated with a Buy at Chardan
03/22/22 Guggenheim
Guggenheim starts Energy Vault at Buy, sees plans as 'ambitious but plausible'
AXDX Accelerate Diagnostics
$1.50 /

+0.08 (+5.63%)

03/09/22 Craig-Hallum
Craig-Hallum downgrades Accelerate Diagnostics to Hold, lowers target to $5
03/09/22 Craig-Hallum
Accelerate Diagnostics downgraded to Hold from Buy at Craig-Hallum
01/14/22 Craig-Hallum
Accelerate Diagnostics price target lowered to $9 from $12 at Craig-Hallum
BLU Bellus Health
$9.07 /

-0.22 (-2.37%)

09/23/22 Jefferies
Bellus Health price target raised to $21 from $14 at Jefferies
08/11/22 H.C. Wainwright
Bellus Health price target raised to $20 from $16 at H.C. Wainwright
07/13/22 RBC Capital
Bellus Health price target raised to $19 from $14 at RBC Capital
07/12/22 H.C. Wainwright
H.C. Wainwright says Bellus set for 'show down' against Merck's gefapixant
AZTA Azenta
$46.60 /

-2.41 (-4.92%)

10/24/22 KeyBanc
Azenta price target lowered to $70 from $90 at KeyBanc
10/04/22 Evercore ISI
Azenta added to 'TAP Underperform' list at Evercore ISI
07/14/22 B. Riley
Azenta price target lowered to $82 from $94 at B. Riley
05/17/22 B. Riley
Azenta price target lowered to $94 from $106 at B. Riley
TXMD TherapeuticsMD
$6.51 /

-0.44 (-6.33%)

TSM TSMC
$72.81 /

-1.02 (-1.38%)

TDUP ThredUP
/

+

SHLS Shoals Technologies
$22.49 /

-0.265 (-1.16%)

QRHC Quest Resource
$8.36 /

-0.47 (-5.32%)

POWW AMMO
$3.16 /

+0.05 (+1.61%)

NRGV Energy Vault
$3.21 /

+0.015 (+0.47%)

NRDY Nerdy
$2.14 /

-0.195 (-8.35%)

HLLY Holley
$2.98 /

-0.215 (-6.74%)

GAN Gan Limited
$1.70 /

+0.02 (+1.19%)

FXLV F45 Training
$3.21 /

-0.26 (-7.49%)

DNA Ginkgo Bioworks
$2.69 /

-0.17 (-5.95%)

DLO dLocal
$22.62 /

-0.18 (-0.79%)

BLU Bellus Health
$9.07 /

-0.22 (-2.37%)

AZTA Azenta
$46.60 /

-2.41 (-4.92%)

AXDX Accelerate Diagnostics
$1.50 /

+0.08 (+5.63%)

ACLX Arcellx
$21.54 /

-0.88 (-3.93%)

  • 19
    Aug
  • 14
    Jul
  • 17
    Jun
  • 21
    Apr
  • 04
    Feb
  • 15
    Dec
TSM TSMC
$72.81 /

-1.02 (-1.38%)

SHLS Shoals Technologies
$22.49 /

-0.265 (-1.16%)

POWW AMMO
$3.16 /

+0.05 (+1.61%)

NRGV Energy Vault
$3.21 /

+0.015 (+0.47%)

GAN Gan Limited
$1.70 /

+0.02 (+1.19%)

FXLV F45 Training
$3.21 /

-0.26 (-7.49%)

TXMD TherapeuticsMD
$6.51 /

-0.44 (-6.33%)

TSM TSMC
$72.81 /

-1.02 (-1.38%)

SHLS Shoals Technologies
$22.49 /

-0.265 (-1.16%)

POWW AMMO
$3.16 /

+0.05 (+1.61%)

NRGV Energy Vault
$3.21 /

+0.015 (+0.47%)

NRDY Nerdy
$2.14 /

-0.195 (-8.35%)

HLLY Holley
$2.98 /

-0.215 (-6.74%)

GAN Gan Limited
$1.70 /

+0.02 (+1.19%)

FXLV F45 Training
$3.21 /

-0.26 (-7.49%)

DNA Ginkgo Bioworks
$2.69 /

-0.17 (-5.95%)

DLO dLocal
$22.62 /

-0.18 (-0.79%)

BLU Bellus Health
$9.07 /

-0.22 (-2.37%)

AXDX Accelerate Diagnostics
$1.50 /

+0.08 (+5.63%)

ACLX Arcellx
$21.54 /

-0.88 (-3.93%)

TXMD TherapeuticsMD
$6.51 /

-0.44 (-6.33%)

TSM TSMC
$72.81 /

-1.02 (-1.38%)

SHLS Shoals Technologies
$22.49 /

-0.265 (-1.16%)

POWW AMMO
$3.16 /

+0.05 (+1.61%)

NRGV Energy Vault
$3.21 /

+0.015 (+0.47%)

FXLV F45 Training
$3.21 /

-0.26 (-7.49%)

DNA Ginkgo Bioworks
$2.69 /

-0.17 (-5.95%)

DLO dLocal
$22.62 /

-0.18 (-0.79%)

ACLX Arcellx
$21.54 /

-0.88 (-3.93%)

Earnings
Holley sees FY22 revenue $695M-$710M, consensus $706.7M » 16:12
11/14/22
11/14
16:12
11/14/22
16:12
HLLY

Holley

$3.00 /

-0.19 (-5.96%)

Sees FY22 adjusted EBITDA…

Sees FY22 adjusted EBITDA of $118M-$124M and Capital Expenditures in the range of $14M-$15M.

ShowHide Related Items >><<
HLLY Holley
$3.00 /

-0.19 (-5.96%)

HLLY Holley
$3.00 /

-0.19 (-5.96%)

10/05/22 Truist
Holley price target lowered to $8 from $10 at Truist
08/12/22 Truist
Holley price target lowered to $10 from $15 at Truist
08/09/22 Imperial Capital
Holley initiated with an Outperform at Imperial Capital
07/29/22 Jefferies
Holley downgraded to Hold on business deceleration at Jefferies
HLLY Holley
$3.00 /

-0.19 (-5.96%)

  • 21
    Apr
HLLY Holley
$3.00 /

-0.19 (-5.96%)

Earnings
Holley reports Q3 EPS 27c, consensus 6c » 16:11
11/14/22
11/14
16:11
11/14/22
16:11
HLLY

Holley

$3.00 /

-0.195 (-6.11%)

Reports Q3 revenue…

Reports Q3 revenue $154.8M, consensus $152.8M. CEO Tom Tomlinson says: "While we are encouraged by the sequential improvement we saw late in the quarter, earnings fell short of expectations. Supply chain constraints peaked in July and then began to ease, allowing us to steadily produce and ship more product in August and September. Underlying demand remained solid, direct to consumer sales were up 11%, and enthusiast engagement accelerated at our Holley-owned events. Channel inventories continued their decline in July and August, before partially recovering on the back of stronger shipments to resellers in September. As supply chain pressures eased throughout the quarter, we saw increased deliveries of key inputs. Our suppliers of automotive-grade microchips also began to resume shipments in the quarter which allowed us to ship more of our popular electronic products in September. These suppliers have also provided better visibility to future shipments. While challenges remain in the supply chain, we are focused on improving availability of parts and increasing shipments. Profitability was negatively impacted by lower production volumes that drove negative operating leverage and manufacturing inefficiencies, especially earlier in the quarter. We also saw higher input costs from both inflationary pressures and from the scarcity of certain automotive-grade microchips. Warranty costs were higher as resellers caught up on a backlog of warranty returns, and higher inbound freight and other overhead costs from earlier in the year are continuing to impact our results as they work their way through inventory. Pricing actions taken mid-year partially offset these cost headwinds. In this challenging environment, we're pleased with the solid demand we've seen for our products at a time when consumers are stressed by inflationary pressures. We believe we are now positioned to convert more of this demand to sales, as supply chain conditions improve, and as we continue to execute operationally. While there is still more work to do on lowering our cost structure and reducing our inventory levels, we are aggressively pursuing numerous improvement opportunities and continue to make solid progress integrating acquired businesses to drive further synergies. We remain confident in the underlying profitability and cash flow generation potential of our business, and we firmly believe that Holley's position as an industry leader with ample runway for long-term profitable growth is unchanged."

ShowHide Related Items >><<
HLLY Holley
$3.00 /

-0.195 (-6.11%)

HLLY Holley
$3.00 /

-0.195 (-6.11%)

10/05/22 Truist
Holley price target lowered to $8 from $10 at Truist
08/12/22 Truist
Holley price target lowered to $10 from $15 at Truist
08/09/22 Imperial Capital
Holley initiated with an Outperform at Imperial Capital
07/29/22 Jefferies
Holley downgraded to Hold on business deceleration at Jefferies
HLLY Holley
$3.00 /

-0.195 (-6.11%)

  • 21
    Apr
HLLY Holley
$3.00 /

-0.195 (-6.11%)

Hot Stocks
Holley names Brian Appelgate as interim COO » 16:09
11/14/22
11/14
16:09
11/14/22
16:09
HLLY

Holley

$2.99 /

-0.2 (-6.27%)

Holley "announced…

Holley "announced the appointment of Brian Appelgate, an industry veteran and operating leader with decades of experience leading teams in the performance automotive aftermarket, to Interim Chief Operating Officer (COO). Mr. Appelgate, who has advised Holley since 2018 as Head of Mergers and Acquisitions, will further align Holley's operations in support of the Company's highest priorities and largest near-term opportunities."

ShowHide Related Items >><<
HLLY Holley
$2.99 /

-0.2 (-6.27%)

HLLY Holley
$2.99 /

-0.2 (-6.27%)

10/05/22 Truist
Holley price target lowered to $8 from $10 at Truist
08/12/22 Truist
Holley price target lowered to $10 from $15 at Truist
08/09/22 Imperial Capital
Holley initiated with an Outperform at Imperial Capital
07/29/22 Jefferies
Holley downgraded to Hold on business deceleration at Jefferies
HLLY Holley
$2.99 /

-0.2 (-6.27%)

  • 21
    Apr
HLLY Holley
$2.99 /

-0.2 (-6.27%)

Over a month ago
Recommendations
Holley price target lowered to $8 from $10 at Truist » 07:35
10/05/22
10/05
07:35
10/05/22
07:35
HLLY

Holley

$4.16 /

-0.09 (-2.12%)

Truist analyst Michael…

Truist analyst Michael Swartz lowered the firm's price target on Holley to $8 from $10 and keeps a Buy rating on the shares as part of a broader research note on Recreation & Leisure. The analyst is updating his model to reflect the impact of rising interest rates and a stronger U.S. dollar over the past 60 days. Concerns regarding the general macro environment and the uncertainty pertaining to consumer spending are also factors that are likely to further pressure near-term earnings outlooks when these companies report their Q3 results over the next 4-6 weeks, Swartz tells investors in a research note.

ShowHide Related Items >><<
HLLY Holley
$4.16 /

-0.09 (-2.12%)

HLLY Holley
$4.16 /

-0.09 (-2.12%)

08/12/22 Truist
Holley price target lowered to $10 from $15 at Truist
08/09/22 Imperial Capital
Holley initiated with an Outperform at Imperial Capital
07/29/22 Jefferies
Holley downgraded to Hold on business deceleration at Jefferies
07/29/22 JPMorgan
Holley downgraded to Neutral from Overweight at JPMorgan
HLLY Holley
$4.16 /

-0.09 (-2.12%)

  • 21
    Apr
HLLY Holley
$4.16 /

-0.09 (-2.12%)

Over a quarter ago
Hot Stocks
Shoals Technologies names Dominic Bardos as CFO » 06:37
08/15/22
08/15
06:37
08/15/22
06:37
SHLS

Shoals Technologies

$26.19 /

+2.03 (+8.40%)

, HLLY

Holley

$6.56 /

+0.275 (+4.38%)

Shoals Technologies Group…

Shoals Technologies Group (SHLS) announced that Dominic Bardos has been appointed as CFO, effective October 3. Prior to joining Shoals, Bardos served as CFO of Holley (HLLY), a manufacturer and distributor of performance automotive products.

ShowHide Related Items >><<
SHLS Shoals Technologies
$26.19 /

+2.03 (+8.40%)

HLLY Holley
$6.56 /

+0.275 (+4.38%)

SHLS Shoals Technologies
$26.19 /

+2.03 (+8.40%)

08/08/22 JPMorgan
Shoals Technologies price target raised to $35 from $31 at JPMorgan
08/04/22 Barclays
Shoals Technologies initiated with an Equal Weight at Barclays
07/25/22 Credit Suisse
Shoals Technologies price target lowered to $20 from $25 at Credit Suisse
07/20/22 JPMorgan
Shoals Technologies price target raised to $31 from $27 at JPMorgan
HLLY Holley
$6.56 /

+0.275 (+4.38%)

08/12/22 Truist
Holley price target lowered to $10 from $15 at Truist
08/09/22 Imperial Capital
Holley initiated with an Outperform at Imperial Capital
07/29/22 Jefferies
Holley downgraded to Hold on business deceleration at Jefferies
07/29/22 JPMorgan
Holley downgraded to Neutral from Overweight at JPMorgan
SHLS Shoals Technologies
$26.19 /

+2.03 (+8.40%)

HLLY Holley
$6.56 /

+0.275 (+4.38%)

  • 21
    Apr
SHLS Shoals Technologies
$26.19 /

+2.03 (+8.40%)

SHLS Shoals Technologies
$26.19 /

+2.03 (+8.40%)

HLLY Holley
$6.56 /

+0.275 (+4.38%)

Recommendations
Holley price target lowered to $10 from $15 at Truist » 09:00
08/12/22
08/12
09:00
08/12/22
09:00
HLLY

Holley

$6.28 /

-0.24 (-3.68%)

Truist analyst Michael…

Truist analyst Michael Swartz lowered the firm's price target on Holley to $10 from $15 but keeps a Buy rating on the shares. The company's Q2 results were not "pretty" and its FY22 performance may not play out in a linear fashion, but many of the issues impacting the quarter should be short-term or transitory in nature, the analyst tells investors in a research note. Swartz adds that he is maintaining his positive long-term view of Holley and continues to recommend the name to longer-term oriented inventors.

ShowHide Related Items >><<
HLLY Holley
$6.28 /

-0.24 (-3.68%)

HLLY Holley
$6.28 /

-0.24 (-3.68%)

08/09/22 Imperial Capital
Holley initiated with an Outperform at Imperial Capital
07/29/22 Jefferies
Holley downgraded to Hold on business deceleration at Jefferies
07/29/22 JPMorgan
Holley downgraded to Neutral from Overweight at JPMorgan
07/29/22 Jefferies
Holley downgraded to Hold from Buy at Jefferies
HLLY Holley
$6.28 /

-0.24 (-3.68%)

  • 21
    Apr
HLLY Holley
$6.28 /

-0.24 (-3.68%)

Syndicate
Holley files to sell 8.3M shares of common stock  16:08
08/11/22
08/11
16:08
08/11/22
16:08
HLLY

Holley

$6.31 /

-0.21 (-3.22%)

 
ShowHide Related Items >><<
HLLY Holley
$6.31 /

-0.21 (-3.22%)

HLLY Holley
$6.31 /

-0.21 (-3.22%)

08/09/22 Imperial Capital
Holley initiated with an Outperform at Imperial Capital
07/29/22 Jefferies
Holley downgraded to Hold on business deceleration at Jefferies
07/29/22 JPMorgan
Holley downgraded to Neutral from Overweight at JPMorgan
07/29/22 Jefferies
Holley downgraded to Hold from Buy at Jefferies
HLLY Holley
$6.31 /

-0.21 (-3.22%)

  • 21
    Apr
HLLY Holley
$6.31 /

-0.21 (-3.22%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.